SCHEMBL27327440

SCHEMBL27327440

CNC(=O)c1ccccc1NC(=O)[C@H](CC(C)C)NCc1ccc(-c2cc(Cl)ccc2Cl)o1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ S1PR4 O95977 11/20 0.44
▸ S1PR5 Q9H228 3/20 0.42
▸ TP53 P04637 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ BLM P54132 1/20 0.40
▸ S1PR2 O95136 5/20 0.39
▸ S1PR3 Q99500 3/20 0.39
▸ HSD17B2 P37059 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ S1PR1 P21453 1/20 0.38
▸ PSMB5 P28074 1/20 0.38
▸ MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27331226 0.91 MAPT (0.49) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27327438 0.91 S1PR4 (0.46) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27327433 0.90 S1PR4 (0.47) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27327436 0.90 S1PR4 (0.47) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27327444 0.87 S1PR4 (0.42) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27327446 0.85 S1PR4 (0.40) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27331219 0.81 MAPT (0.51) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27329641 0.81 MAPT (0.49) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27331222 0.81 MAPT (0.51) S1PR4S1PR5TP53MAPTBLM
SCHEMBL27327257 0.81 S1PR4 (0.48) S1PR4S1PR5TP53MAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024103400-A1 POLYCYCLIC COMPOUND AS GPR75 ACTIVATOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 水木未来(北京)科技有限公司 2024-05-23 — — WO disclosed
Send feedback